Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

Yale operates first the BATMAN procedure in CT, a less invasive heart treatment offering faster recovery and new hope for ...

Buoyed by $110m in funding three months ago, Capstan Medical has reported the first-in-human cases with the mitral technology ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

C Medical Technologies Inc. raised $175 million in a series D financing round led by Boston Scientific Corp. The financing will support the regulatory trials and commercialization of the Altavalve ...

C Medical Technologies announced today that it closed a Series D financing round resulting in gross proceeds of up to $175 ...

We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

In a groundbreaking series of surgeries, doctors at Duke Health have successfully performed the world's first living mitral ...

DURHAM, N.C. (WTVD) -- In a medical breakthrough at Duke Health in Durham, a group of doctors performed the world's first living mitral valve replacement, which helped save the lives of two girls ...